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Abstract
Infection by Leptospira interrogans has been causally associated with human and equine uveitis. Studies in our laboratories
have demonstrated that leptospiral lipoprotein LruA and LruB are expressed in the eyes of uveitic horses, and that
antibodies directed against LruA and LruB react with equine lenticular and retinal extracts, respectively. These reactivities
were investigated further by performing immunofluorescent assays on lenticular and retinal tissue sections. Incubation of
lens tissue sections with LruA-antiserum and retinal sections with LruB-antiserum resulted in positive fluorescence. By
employing two-dimensional gel analyses followed by immunoblotting and mass spectrometry, lens proteins cross-reacting
with LruA antiserum were identified to be a-crystallin B and vimentin. Similarly, mass spectrometric analyses identified b-
crystallin B2 as the retinal protein cross-reacting with LruB-antiserum. Purified recombinant human a-crystallin B and
vimentin were recognized by LruA-directed antiserum, but not by control pre-immune serum. Recombinant b-crystallin B2
was likewise recognized by LruB-directed antiserum, but not by pre-immune serum. Moreover, uveitic eye fluids contained
significantly higher levels of antiibodies that recognized a-crystallin B, b-crystallin B2 and vimentin than did normal eye
fluids. Our results indicate that LruA and LruB share immuno-relevant epitopes with eye proteins, suggesting that cross-
reactive antibody interactions with eye antigens may contribute to immunopathogenesis of Leptospira-associated recurrent
uveitis.
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Introduction
Infectious disease caused by spirochetes of the genus Leptospira is
a veterinary and public health problem of global proportions [1],
[2]. Humans and other mammals are exposed to the organism
when they contact groundwater contaminated with urine from
carrier animals. The disease in humans varies from a mild flu-like
form to a more severe syndrome involving multiorgan failure and
death [3]. Uveitis is a common complication of systemic infection
in humans affecting one or both eyes [4]. In equines, infection is
mainly associated with spontaneous abortion in mares and
recurrent uveitis [3]. After an initial infection, some horses
develop a recurrent inflammation of the uveal tract of eye (iris,
ciliary body and choroid), known as equine recurrent uveitis
(ERU) or ‘moon blindness’. First described in 1819 by James
Wardrop as a ‘‘specific inflammation’’ of uveal origin, it is the most
common cause of blindness in horses worldwide [5,6] with a
prevalence of approximately 8–10% in the United States [7].
Onset of the disease is usually acute with variable degrees of
severity and duration. The acute phase is followed by a quiescent
phase of no or low inflammation [8]. Subsequent recurrence of
inflammation results in pronounced lesions with guarded progno-
sis for preservation of visual acuity [8,9,10,11]. The Appaloosa
breed and horses with MHC class I haplotype ELA-A9 have been
observed to be at increased risk of developing uveitis [12,13].
Leptospira interrogans serovar Pomona is the most common and
well-documented infectious cause of ERU in the United States
[14]. Its association with pathogenic leptospires has been well
established by presence of high titers of leptospiral agglutinins in
the blood and aqueous humor [15,16], by isolation of Leptospira
from ocular fluids [17,18] and the detection of leptospiral DNA by
polymerase chain reaction in vitreous humor of uveitic horses [17].
Initial evidence of the association was provided by Morter et al.
[19] when they induced uveitis in ponies by subcutaneous injection
of guinea pig blood containing live L. interrogans serovar Pomona.
The resulting ocular pathology in experimental ponies was found
to be similar to that of spontaneous cases of Leptospira-associated
ERU.
By using ERU uveitic fluids to screen a lambda phage library of
L. interrogans, we identified leptospiral lipoproteins, LruA and LruB,
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fluids contained significantly higher levels of immunoglobulin A
(IgA) and IgG specific for LruA and LruB than did companion
sera, indicating strong local antibody responses. Moreover,
monospecific antiserum to LruA and LruB reacted with extracts
of equine ocular tissue. In the present study we have examined the
reactivity of LruA- and LruB-antiserum with sections of lens and
retinal tissue and identified the ocular proteins involved in the
interaction. In addition, the significance of the identified
autoantigens was assessed by measuring their immuno-reactivities
in eye fluids of uveitic and healthy animals.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with relevant
national and international guidelines, and all animal work was
approved by the University of Kentucky Institutional Animal Care
and Use Committee (IACUC#2009-0477).
Eye fluids and eye tissue extracts
Eye fluids and companion sera from horses of varied age, breed,
and origin were obtained from a commercial horse slaughter plant
in North America. Eyes with gross evidence of uveitis were
enucleated after slaughter, and aqueous humor was removed with
a 10-ml syringe and stored at 220uC. The eyes were placed in
10% formaldehyde for subsequent embedding, sectioning, and
staining with hematoxylin and eosin for histological examination.
Eye fluids and sera were assayed for antibodies to serovars
Pomona, Canicola, Icterohemorrhagiae, Hardjo, Bratislava, and
Grippotyphosa in the microscopic agglutination test (MAT) [20].
Eye fluids and sera from each horse were also tested by ELISA
using recombinant antigens LigA, Lk73.5 and Qlp42). Extracts
were prepared from the ciliary body, cornea, lens, and retina of a
normal eye from a young horse serologically negative for Leptospira,
as described by Parma et al., 1985 [21].
Recombinant protein and antiserum
Identification, cloning, and expression of recombinant LruA and
LruB has been described previously [20]. Briefly, following PCR
amplification of chromosomal DNA of L. interrogans serovar Pomona
type kennewicki (JEN4) with gene-specific primers, amplicons were
inserted into pET-15b (Novagen, Madison, WI). Recombinant
plasmids were transformed into Escherichia coli BL21 (DE3)
(Novagen, Madison, WI), and recombinant His-tagged proteins
were isolated and their purity tested as previously described [20].
Three New Zealand white rabbits were immunized to obtain
polyclonal antiserum directed against recombinant LruA.
Immuno-fluorescence assay (IFA)
Lenses were dissected from the eyes of three healthy horses
immediately after euthanasia, frozen in liquid nitrogen, stored
at 270uC, and later embedded in tissue freezing medium for
mounting in a Tissue-Tek (Miles, Elkhart, IN) cryostat. Sections
(8–10 m) were placed on glass slides treated with 2% solution of
3-aminopropyltriethoxysilane in acetone. The sections were fixed in
acetone at 20uC for 20 min followed by two washes with phosphate
buffer saline (PBS, pH 7.4) for 5 min each. Blocking was performed
using 2% bovine serum albumin (BSA; Sigma, St. Louis, MO) in
PBS for 30 min. Sections were again washed thrice with PBS and
incubated with 1:100 polyclonal rabbit antiserum or pre-immune
serum overnight at 4uC in a humidifying chamber. Sections were
washed three times for 5 min each and subsequently incubated with
1:250 dilution of FITC conjugated goat anti-rabbit IgG (Invitrogen,
Carlsbad, CA) for 1 h at room temperature in a humidifying
chamber. Slides were mounted in a mounting medium containing
anti-fading reagent Mowiol (EMD Chemicals, Gibbstown, NJ) and
screened by epifluorescence microscopy (Axioscope-20; Zeiss,
Thornwood, NY, USA) and image analysis was carried out using
the QUIPS-XL and QUIPS-AKS system (Vysis, Downer’s Grove,
IL, USA). The same IFA protocol as above was used for testing lens
tissues obtained from two healthy sheep.
Two dimensional polyacrylamide gel electrophoresis
Lenticular and retinal aqueous extracts were separated by two-
dimensional polyacrylamide gel electrophoresis (2-D PAGE) using
MultiPhor-II system (GE Healthcare, Piscataway, NJ). Briefly, the
aqueous extracts were subjected to isoelectric focusing using precast
IPG strips (Bio-Rad, Hercules, CA) for 3000 V? h (500 V, 6 h,
10uC). Strips were then equilibrated and subjected to conventional
sodium dodecylsulfate-12.5% polyacrylamide gel electrophoresis
(SDS-PAGE). Gels were either stained with SYPRO Ruby
(Invitrogen) or transferred to nitrocellulose membranes for
immunoblot analysis with LruA- or LruB-directed antiserum.
Immunoblot positive protein spots were extracted from gels and
analyzed by matrix-assisted laser desorption ionization-time-of-
flight (MALDI-TOF) mass spectrometry (University of Louisville
Mass Spectrometry Core Laboratory, Louisville, KY). Spectrome-
try outputs were compared with known sequences using Mascot
(Matrix Science, Boston, MA).
Eye protein antibody assays
Recombinant human a-crystallin B (Abcam, Cambridge, MA),
purified vimentin from bovine lens (Sigma) or human recombinant
b-crystallin B2 (Abnova) were separated by SDS-PAGE, trans-
ferred to a nitrocellulose membrane and blocked with 5% nonfat
dry milk in Tris-buffered saline (20 mM Tris, 150 mM NaCl,
0.05% Tween 20, pH 7.5). Membranes were incubated with LruA
or LruB-antiserum (1:400) followed by incubation with protein G
conjugated to horseradish peroxidase (Zymed, San Francisco, CA).
Membranes were developed with the SuperSignal West Pico
enhanced chemiluminescence substrate (Pierce), and bands were
visualized with BioMax Light film (Kodak).
ELISA measured alpha-crystallin B, vimentin and b-crystallin
B2 antibody levels in leptospiral uveitic and normal eye fluids as
described previously [20,22]. Briefly, ELISAs were performed in
Maxisorp 96-well plate wells (Nalge-Nunc, Rochester, NY) coated
with 200 ng human recombinant alpha-crystallin B (Abcam),
Author Summary
Leptospira is the most common infectious cause of uveitis,
a potentially debilitating inflammation of the eye. In our
earlier work, we discovered that eye fluids of uveitic horses
contain high levels of antibodies directed against novel
leptospiral proteins, which we named LruA and LruB
(Leptospiral recurrent uveitis associated proteins A and B).
Significantly, antibodies raised against LruA and LruB also
recognize lens and retinal tissue. We have now identified
the cross-reactive eye proteins as alpha-crystallin B,
vimentin and beta-crystallin B2. We also demonstrated
that ocular fluids from uveitic horses contain high levels of
antibodies recognizing alpha-crystallin B, vimentin and
beta-crystallin B2. These data suggest that antibodies
directed against leptospiral LruA and LruB during infection
can also react with eye proteins, alpha-crystallin B,
vimentin and beta-crystallin B2, potentially contributing
to the severity of this eye disease.
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b-crystallin B2 (Abnova) followed by blocking with 5% nonfat dry
milk. Uveitic and normal eye fluids (1:100) were added and
incubated for 1 h at 37uC. Bound antibodies were detected using
HRP conjugated Protein G (1:4000; Zymed, San Francisco, CA).
Plates were developed using ready-to-use 3,39,5,59-tetramethyl
benzidine substrate solution (1-Step Turbo TMB-ELISA, Thermo
Scientific, Rockford, IL). Reactions were stopped by addition of
2N H2SO4,5 0ml/well. Absorbance was read at 450 nm in a
Spectramax plate reader using SoftMax Pro (Molecular Devices,
Sunnyvale, CA). Statistical analyses were performed using
Student’s t-test assuming unequal variances.
Results
Cross-reactivity of LruA and LruB with equine lens and
retina, respectively
In a previous study [20] LruA-antiserum was shown to
recognize a ,22 kDa protein in lens extract and a ,65 kDa
protein in ciliary body extract. In the same work, LruB-antiserum
reacted with a ,30 kDa band in retinal extract. To further
examine the observed cross-reactivity between equine ocular tissue
and LruA and LruB specific antisera, immunofluorescent assays
were performed. Frozen lenticular and retinal tissue sections
(8–10 m) were fixed, blocked and incubated with antiserum or
preserum to LruA and LruB (diluted 1:100). The lens fibers
showed uniform homogenous pattern of fluorescence when
incubated with LruA-specific antiserum but not with normal
rabbit serum (Figure 1A and B).
Similarly, fluorescence was observed when equine retinal tissue
sections were incubated with LruB-specific antiserum but not with
normal rabbit serum (Figure 1C and D). The positive
fluorescence seen in retinal tissue incubated with LruB-antiserum
was restricted to one or more deeper retinal layers, which include
the inner limiting membrane, layer of nerve fiber and may be the
ganglion cell layer, in contrast to a diffused positive fluorescence
seen in lens tissue sections incubated with LruA-antiserum. In
addition, sclera and choroid were devoid of any fluorescence in the
same tissue section (Figure 1).
Similar results were obtained with lenticular tissues from a
healthy sheep. Sections of sheep lens incubated with LruA-
antiserum showed positive fluorescence but not when these
sections were incubated with pre-immune serum (not shown).
The reactivities of equine and sheep lenticular tissue sections with
LruA-antiserum indicated that the observed interaction is not
unique to equines lens.
Identification of lenticular and retinal proteins cross-
reactive with LruA and LruB
To identify the eye protein(s) recognized by LruA-directed
antibodies, proteins in equine lenticular extract were separated on
two-dimensional polyacrylamide gels, transferred to nitrocellulose
membranes and probed with LruA-specific antiserum (Figure 2 A
and B). LruA-antiserum recognized protein spots with apparent
Figure 1. LruA and LruB-antiserum reacts with lenticular and retinal tissues. (A) Photomicrographs showing uniform homogeneous
fluorescence in a section of equine lens incubated with LruA-antiserum (1:100) but not with preserum (B)( 6100). (C) Photomicrographs showing a
positive fluorescence in a frozen section of equine retina incubated with LruB-antiserum (1:100) but not with pre-immunization serum (D)( 6100).
Inset (6400).
doi:10.1371/journal.pntd.0000778.g001
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blot was aligned with the stained gel, to locate the corresponding
protein spots which were then subjected to mass spectrometric
analysis. The 20 and 60 kDa protein spots were identified as a-
crystallin B and vimentin, respectively (Table 1) with 66% and
44% coverage (not shown). Alpha-crystallin B and vimentin have
molecular masses of 20188 Daltons and 53727 Daltons, respective-
ly. Attempts to identify ciliary body protein(s) reactive to LruA-
specific antiserum by this method have not yet been successful.
Similarly, LruB-antiserum recognized three spots of retinal
proteins (Figure 2C and D), which were identified by mass
spectrometry to be b-crystallin B2 (Table 1).
LruA-directed antiserum recognizes human eye lens a-
crystallin B and vimentin
Mammalian a- c r y s t a l l i nBp r o t e i ns e q u e n c e sa r eh i g h l y
conserved across species (Figure 3). Therefore, purified
Figure 2. Two-dimensional electrophoretic analysis of proteins in equine lenticular and retinal tissue extracts. (A) Lens extract
separated on a polyacrylamide gel stained with the fluorescent dye SYPRO-Ruby. (B) Lens proteins transferred from a second gel to nitrocellulose
membrane and blotted with LruA-antiserum. The arrowheads indicate the protein spots excised from the stained gel for analysis by mass
spectrometry. (C) Retinal extract separated on a polyacrylamide gel stained with SYPRO-Ruby. (D) Retinal proteins transferred from a second gel to
nitrocellulose membrane and blotted with LruB-antiserum. Three protein spots (numbered 3, 4 and 5) were excised from the stained gel for analysis
by mass spectrometry. Results of mass spectrometric analyses are tabulated in Table 1.
doi:10.1371/journal.pntd.0000778.g002
Table 1. Identification of ocular proteins cross-reactive with
LruA and LruB antiserum (Figure 2) by mass spectrometry.
Protein
Spot Identified Protein Accession Number
Predicted
Mass*
Spot 1 Alpha-crystallin chain B CYBOAB 20024
Spot 2 Vimentin VIM_BOVINE 53752
Spot 3 Beta-crystallin chain B2 Q2 LEC2_CANFA 23318
Spot 4 Beta-crystallin chain B2 Q2 LEC2_CANFA 23318
Spot 5 Beta-crystallin chain B2 Q2 LEC2_CANFA 23318
*Peptide masses were analyzed using the MASCOT Database search engine v1.9
(www.matrixscience.com) (Matrix Science Ltd.).
doi:10.1371/journal.pntd.0000778.t001
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analyses to confirm a-crystallin B as a cross-reacting antigen.
LruA-directed antiserum, but not the pre-immune serum,
reacted with recombinant a-crystallin B, indicating that this
lenticular protein is indeed the cross-reacting antigen
(Figure 4A and B).
Figure 3. Multisequence alignment of alpha-crystallin B of horse (Equus caballus), man (Homo sapiens), cow (Bos taurus), sheep (Ovis
aries) and mouse (Mus musculus) using T-COFFEE Version 5.05 [http://www.tcoffee.org].
doi:10.1371/journal.pntd.0000778.g003
Figure 4. LruA antiserum reacts with recombinant human alpha-crystallin B and purified vimentin. (A) Immunoblot showing reactivity
of LruA-specific antiserum (1:400) with recombinant human alpha-crystallin B (1mg). (B) Pre-immune serum (1:400) did not react with this protein. (C)
Immunoblots showing reactivity of LruA-antiserum (1:400), but not the pre-immunization serum (D), with purified vimentin (1mg). Molecular mass
markers are indicated in kilodaltons.
doi:10.1371/journal.pntd.0000778.g004
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vimentin is 91% (not shown). So, purified vimentin from bovine
lens was used in immunoblot to examine its reactivity to LruA-
directed antiserum. LruA-directed antiserum but not the pre-
immune serum, reacted with purified vimentin in an immunoblot
(Figure 4C and D).
LruB-directed antiserum recognizes human b-crystallin
B2
Recombinant human b-crystallin B2 was used in immunoblot
analyses to confirm b-crystallin B2 as a cross-reacting antigen.
LruB-directed antiserum, reacted with recombinant b-crystallin
B2, indicating that this lenticular protein is indeed the cross-
reacting antigen (Figure 5A). Pre-immunization serum did not
react with b-crystallin B2 (Figure 5B).
Antibodies directed to alpha-crystallin B, vimentin and b-
crystallin B2 in uveitic fluids
The biological significance of a-crystallin B, vimentin and b-
crystallin B2 as a cross-reacting antigen was investigated by
examining antibody levels against these lenticular or retinal
proteins in eye fluids obtained from clinical cases of leptospiral
uveitis and healthy controls. ELISA was performed using
recombinant a-crystallin B, purified vimentin or recombinant b-
crystallin B2 as coating antigens. Antibody levels to a-crystallin B,
vimentin and b-crystallin B2 (Figure 6) were found to be
significantly elevated in uveitic compared to normal eye fluids
(p,0.001).
Discussion
The pathogenesis of leptospiral uveitis is currently under
investigation and several possible mechanisms have been proposed
[6,9,12,17,20,21,23,24,25,26,27,28]. How leptospires survive in
the eye, causing breach of the ocular immune privilege and
initiation of pro-inflammatory changes, is not understood.
Although direct Leptospira-mediated injury to eye structures is
possible, a growing body of evidence suggests that autoimmune
responses to ocular tissue components play a significant role in
pathogenesis [6,9,12,17,20,21,22,23,24,25,26,27,28]. Parma et al.
[21] demonstrated reactivity of anti-equine cornea antibodies with
Leptospira and binding of Leptospira and cornea specific antibodies to
equine cornea [21]. Subsequently, an antigenic relationship
between equine lens and leptospires was proposed by the same
group [27]. Electron microscopic studies revealed that the
antigenic protein of L. interrogans that shares epitopes with equine
cornea and lens is not exposed on the outer surface of leptospires
[28]. However, in those studies, specific leptospiral and/or ocular
proteins involved in the antigenic relationship were not identified.
In this study, we have shown that the lenticular proteins, a-
crystallin B and vimentin, cross-react with LruA and retinal
protein, b-crystallin B2, cross-reacts with LruB confirming our
previous observations of reactivity of LruA and LruB antibodies
with equine lens and retina, respectively.
Alpha-crystallin B and vimentin are critical for maintaining lens
clarity and thus visual acuity [29]. Alpha-crystallin is the principal
constituent of the lens and acts as a molecular chaperone that
keeps other lens proteins from precipitating [30]. Disruption of this
function may lead to impairment of light refraction and potentially
vision. Alpha-crystallin B is a 175-amino acid small heat shock
protein and shares high interspecies sequence homology
(Figure 3). Its involvement in several disease states including
uveitis, Alexander disease, Alzheimer’s, Creutzfeldt-Jacob disease
and multiple sclerosis are under investigation [31,32,33]. In
addition to lens and central nervous system (CNS), it is also present
in many other tissues including skeletal muscles and kidney
epithelial cells.
Vimentin is an important structural determinant in the human
lens cell and is mainly expressed in the epithelium of the lens. In a
previous study, high expression of vimentin was negatively
correlated with the normal differentiation of the lens fibers. In
that study, animals developed pronounced cataract and extensive
lens degeneration as a result of impairment of lens fiber cell
differentiation [34]. A study on expression of vimentin in lens
epithelium of age-related cataract suggested that damage to the
lens epithelial cells might initiate a decrease in vimentin expression
leading to degradation of the lens cytoskeleton [35]. Recently,
small interfering RNA (siRNA) mediated downregulation of
human pigment epithelium-derived factor (PEDF) expression in
primary human lens epithelial cells was shown to result in a
decrease in the expression of vimentin and increase of a-crystallin
B expression [29]. Interestingly, serum and ocular levels of PEDF
have been shown to decrease in uveitic horses, but not the normal
horses [36,37].
Beta-crystallin B2 is present in lens and non-lenticular tissues,
including the retina. The appearance and accumulation of beta-
crystallin B2 in neural retina coincides with its functional
maturation [38]. Recently, antibodies against a-crystallin A, a-
crystallin B and b crystallin B1 were found to be significantly
elevated in uveitis patients and seroreactivity was found to be
significantly associated with cortical cataract [39]. In another
study, C ¸elet and colleagues [31] reported an elevated humoral
response to a-crystallin B in neuro-Behc ¸et’s disease and Guillain-
Barre ´ syndrome. We recently demonstrated that LruA and LruB
were recognized by antibodies from Behc ¸et’s and Fuchs uveitis
patients, without any evidence of those patients having been
exposed to Leptospira [22]. Both of these diseases are believed to be
autoimmune diseases [22,40,41,42,43,44,45]. In the same study,
Figure 5. LruB antiserum reacts with human b-crystallin B2. (A)
Immunoblots showing reactivity of LruB-antiserum (1:400) with
recombinant human b-crystallin B2(1mg). (B) Pre-immune serum
(1:400) did not react with b-crystallin B2. Molecular mass of
recombinant b-crystallin B2 is 50.4 kDa. Molecular mass markers are
indicated in kilodaltons.
doi:10.1371/journal.pntd.0000778.g005
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antibodies recognizing LruA and LruB and the presence of
cataract [22]. The high levels of antibodies cross-reactive with
LruA and LruB in patients with Fuchs or Behc ¸et’s uveitis, and the
strong association of LruA and LruB antibodies with cataract
could be due to increased levels of antibodies to the common
autoantigens, a-crystallin B, vimentin and b-crystallin B2, in those
diseases. Also, elevated levels of LruA- and LruB-antibodies in sera
of human patients with leptospiral uveitis [22] and reactivity of
LruA- and LruB-antiserum with human alpha-crystallin B and b-
crystallin B2 suggest a similar phenomenon in human leptospiral
uveitis. We are presently pursuing those hypotheses to determine
the causes of leptospiral and non-leptospiral uveitis.
A linear amino acid similarity or a conformational homology
between microbial and host proteins is a potential basis for
molecular mimicry. The limited linear amino acid similarity
between these leptospiral proteins and their respective cross-
reacting ocular proteins (not shown) suggests similarities at the
conformational level. Studies to identify the cross-reactive epitopes
are underway.
In conclusion, we have identified two lens proteins and a retinal
protein that react with antiserum directed against LruA and LruB,
leptospiral proteins expressed in uveitic eyes. The presence of
antibodies recognizing a-crystallin B, vimentin and b-crystallin B2
in uveitic, but not normal eye fluids, strongly suggests a role for
these antibodies in Leptospira-associated recurrent uveitis. In the
immune privileged ocular environment, it is likely that the early
phase of leptospiral infection involves a non-inflammatory
immune responses specific for LruA and LruB. Resulting
antibodies may interact with cross-reacting proteins in lens and
retinal tissues and may therefore initiate a process of desequestra-
tion of these ocular antigens, and possibly other components. How
early after an initial infection this interaction results in develop-
ment of the changes in eye, and what other pro-inflammatory
changes, if any, are required remains to be determined.
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